A Clinical Research site network
Dedicated to Patient-Centic and Data-Driven Research
Welcome to Centex Studies
Centex Studies is a multi-specialty clinical research site network with five locations across Texas and Louisiana. Collectively our sites have conducted over 500 research studies, or clinical trials, on a wide variety of health conditions.
Providing the best care for our patients and the best data for our sponsors are our top priorities. Our experience, coupled with the most advanced research technology, is what ranks Centex Studies far above all other research sites.
Looking to get involved in research?
We are always looking for new PIs, Sub-Is, and referring physicians. Click here to find out how to get involved today!
Looking for diversity in your trial?
That, combined with our experience and technology, enables us to deliver the most accurate data in less time. Click here to learn more about our capabilities!
What Makes Centex Studies Different?
No one can do everything, but everyone can do something! If you're interested in learning more about our sites, our clinical trials, how to volunteer, or joining our physician referral network, email us today!
Become a VOLUNTEER
HELP US ADVANCE MEDICINE FOR FUTURE GENERATIONS!
Our Latest BlogView all
Nov 5, 2021 8:26:17 AM
COVID, FLU, RSV OH MY! WHAT’S THE DIFFERENCE?
Staying sane in a world where RSV, the Flu, and COVID-19 are present can be a bit difficult when it feels like these three viruses are just lurking around waiting to strike. The biggest question that has been on everyone’s mind is, what is the difference between all three of these very dangerous...
In the NewsView all
Mar 16, 2021 4:13:28 PM
COVID-19 VACCINES FOR EXPECTING MOMS, CHILDREN, & TEENS AVAILABLE SOON
Research studies evaluating potential options will begin soon at Centex Studies – Houston
February 9, 2021 HOUSTON, TX – Wanting to protect expecting mothers and our children is only natural, but without the proper research, we have no way of knowing what is safe and what isn’t. So far, no...